financial_disclosure

Berlin – September 11, 2026 -- Germany's federal government has proposed a 2027 budget with total expenditures of €555 billion, including a record €118 billion in investment spending, as parliamentary budget deliberations began this week with the bill's first reading in the Bundestag.

Customs enforcement funding rises to €238.8 million to fight tax fraud

Investment spending for German customs authorities is set to increase by approximately €36 million to €238.8 million. The funds will finance digital forensic systems capable of extracting data from seized smartphones and hard drives in a court-admissible, serialized manner.

Special fund allocates €235 million for AI-driven investigations

An additional roughly €235 million from Germany's special fund will support the expansion of AI-assisted investigative work and automated, secure data exchange between customs authorities.

Abu Dhabi – September 11, 2026 -- Assets Under Management within ADGM rose 54% year-on-year in the first half of 2026, while active licences climbed to 13,974, cementing Abu Dhabi's status as the largest international financial centre in the MEASA region by that metric.

Fund managers and AUM expand at double-digit pace

The number of fund and asset managers based in ADGM reached 190, up 23% from 154 a year earlier, with 11 added in the second quarter alone -- the centre's strongest quarterly increase to date. Funds managed from ADGM rose 32% to 276. Managers that established operations in ADGM during H1 2026 collectively oversee more than USD 2.1 trillion in global assets under management.

Delray Beach, Fla. – September 11, 2026 -- The global medical supplies market is projected to grow from $194.76 billion in 2026 to $248.03 billion by 2031, a compound annual growth rate of 7.39%, according to new research from MarketsandMarkets.

Asia Pacific outpaces global growth rate as diagnostic demand accelerates

Asia Pacific is set to register the fastest regional CAGR at 10.2% through 2031, outstripping the global average as healthcare infrastructure expands across the region. By product type, infusion and injectable supplies will grow fastest at a 9.0% CAGR, while diagnostic supplies held the largest share in 2025 and are expected to post the quickest growth of any category over the forecast period, driven by rising chronic and infectious disease burdens and expanding preventive screening programs.

Hollywood, Fla. – September 11, 2026 -- Memorial Healthcare System reported $3.8 billion in operating revenue for fiscal year 2026, a 7.7% increase over the prior year, as the South Florida public health system posted its strongest financial results to date.

Operating income surges more than 60% to $220.7 million

Excess of revenues over expenses reached a record $487.6 million, up 20.3% year-over-year. Memorial's net position grew by more than $503 million, closing the fiscal year at $4.1 billion.

Hospital outpatient visits climb 5.7% amid rising patient acuity

Patients increasingly sought advanced specialty care through Memorial's cancer, cardiac, neuroscience and pediatric programs, pushing acuity levels higher across the system.

Raleigh – September 11, 2026 -- The North Carolina Railroad Company (NCRR) has awarded $1 million in Build Ready Sites grants to Harnett County and Greensboro, splitting the funding evenly at $500,000 each to prepare rail-served industrial properties for future manufacturers. NCRR simultaneously opened its next competitive grant round, with applications accepted through October 2, 2026.

Bogotá – September 8, 2026 -- Avianca has secured financing of up to US$300 million arranged through Citibank and backed by Brazil's Export Credit Insurance program (SCE) to fund maintenance, repair and overhaul work on its CFM56 aircraft engines at GE Aerospace's Celma MRO facility in Brazil.

Deal marks first non-Brazilian airline financing under ABGF's export credit framework

The transaction, structured with support from the Brazilian Agency for Management of Guarantee Funds and Guarantees (ABGF), is the first instance of a non-Brazilian carrier accessing this financing mechanism for aircraft engine maintenance services. The structure is designed to support the export of high-value Brazilian technical services.

Stamford, Conn. – – September 11, 2026 -- Curaleaf Holdings, Inc. released a fact sheet countering what it called inaccurate statements by Aurora Cannabis Inc. regarding Curaleaf's proposal to acquire the company, arguing its offer represents one of the highest premiums in a decade of Canadian M&A.

Curaleaf says its bid carries a 110% premium once Aurora's cash is excluded

Curaleaf's headline offer reflects a 45% premium, which the company says ranks among the higher Canadian M&A premiums of the past ten years. Stripping out cash on Aurora's balance sheet, Curaleaf calculates the effective premium at 110%. Curaleaf noted Aurora has continued issuing shares through an At-the-Market program at prices below the value implied by the offer, even after the bid was made public.

Stockholm – September 11, 2026 -- SciBase Holding AB (STO: SCIB) has received an additional order worth roughly $0.6 million, or approximately SEK 5 million, from Castle Biosciences (NASDAQ: CSTL) to accelerate an ongoing clinical study and prepare a second trial under their dermatology collaboration.

Order covers Nevisense Go devices and electrodes for atopic dermatitis research

The order includes both SciBase's portable Nevisense Go pen device and associated electrodes. Deliveries are scheduled to begin in the fourth quarter of 2026.

Collaboration targets relapse prediction in atopic dermatitis patients

SciBase and Castle Biosciences entered a collaboration and license agreement in 2025. The first joint study under that agreement aims to predict relapses in atopic dermatitis and is currently underway, with the new order funding both faster progression of that trial and groundwork for a follow-up study.

Dallas – September 11, 2026 -- NFL All-Pro Micah Parsons has taken an equity stake and board seat at RejuvStem, a Cancún, Mexico-based regenerative wellness company, as the firm looks to widen its footprint beyond athletic recovery into the broader preventive health market.

Parsons moves from endorsement to equity investor and board member

The deal, negotiated by Athletes First, the sports representation and marketing agency that handles Parsons' on- and off-field business, gives him formal roles as investor, board member and brand ambassador rather than a standard sponsorship arrangement. He will advise RejuvStem on brand growth and strategic initiatives, working to position the company's regenerative therapies and personalized wellness programs to a wider consumer base that includes non-athletes seeking preventive care.

Chicago/Leipzig – September 11, 2026 -- CME Group has agreed to take over the European Energy Exchange's dairy derivatives business, marking its first entry into the European dairy market and adding to a U.S. dairy franchise where volumes have risen 73% over five years.

EEX will phase out its dairy indices by the end of 2027

Under the agreement, EEX intends to transition the suite of indices underpinning its existing dairy futures contracts to CME Group before the end of 2027, including the European butter and skimmed milk powder indices. CME Group plans to launch its own European dairy indices, futures and options following the transition. EEX said dairy futures trading will remain available for existing listed maturities during the transition, with no immediate changes to the setup of the pan-European butter and WECI indices.